Clinical trial

Clinical Utility Trial for the SomaLogic CVD-T2D Test

NCT05237271

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-03-15

PhaseNA

Study timeline

Study start (actual)2022-03-15Date precision: day

Registry last updated2022-08-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiovascular Diseasesunresolved

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D)OTHER

Educational Materials on the CVD-T2D and Bundled Metabolic PanelOTHER

Sponsors & collaborators

Qure Healthcare, LLClead sponsor

SomaLogic, Inc.collaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05237271 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.